Dimetindene
Generic name
Dimetindene
Brand name
ATC Code
R06AB03
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
There is no data known about the kinetics of this drug in children.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Allergic conditions, itching |
|---|
|
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Using it can result in reduced capacity to react and concentrate. Antihistamines can induce mental agitation in younger children (SmPC Fenistil).
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications in children
Do not use in children under one year of age because the sedative effect may lead to periods of respiratory arrest during sleep.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
ANTIHISTAMINES FOR SYSTEMIC USE
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Aminoalkyl ethers | ||
|---|---|---|
| R06AA04 | ||
| R06AA52 | ||
| R06AA02 | ||
| Phenothiazine derivatives | ||
|---|---|---|
| R06AD01 | ||
| R06AD08 | ||
| R06AD02 | ||
| Piperazine derivatives | ||
|---|---|---|
| R06AE07 | ||
| R06AE03 | ||
| R06AE09 | ||
| R06AE05 | ||
| Other antihistamines for systemic use | ||
|---|---|---|
| R06AX18 | ||
| R06AX29 | ||
| R06AX02 | ||
| R06AX27 | ||
| R06AX26 | ||
| R06AX17 | ||
| R06AX13 | ||
| R06AX25 | ||
| R06AX28 | ||
References
- Novartis, SPC Fenistil (RVG 01528) 02-06-2017
- Rademaker C.M.A. et al, Geneesmiddelen Formularium voor Kinderen, 2007
- GlaxoSmithKline, SmPC Fenistil® Gel (Reg-Nr. 48 646), 05/2017
- DAZ.online, Individuell für Kinder, Accessed March 16, 2018
- Breitkreutz J, Boos J, Paediatric and geriatric drug delivery. , Expert Opin Drug Deliv, 2007, 4(1), 37-45
- Novartis, SmPC Fenistil® Injektionslösung (1457.00.00), 10/2013
- GlaxoSmithKline, SmPC Fenistil® Tropfen (6336562.00.02), 02/2017
- GlaxoSmithKline, SmPC Fenistil® Dragees (6336562.00.01), 08/2017
- Gelbe Liste Online, Gelbe Liste Online, Accessed March 16, 2018
- Breitkreutz J, Boos J, Paediatric and geriatric drug delivery., Expert Opin Drug Deliv, 2007, 4(1), 37-45
Changes
Therapeutic Drug Monitoring
Overdose
